119th Congress
H.R. 3288
Access to Prescription Digital Therapeutics Act of 2025
- Introduced
- In committee
- Passed House
- Passed Senate
- To President
- Became law
- Sponsor
- Kevin Hern(R-OK)
- Introduced
- May 8, 2025
- Policy area
- Health
- Committees
- House Committee on Energy and Commerce; House Committee on Ways and Means
- Official text
- Introduced in House · Congress.gov page
Cosponsors (10)
Original cosponsors (1)
- Mike Thompson (D-CA)
Added later (9)
- Angie Craig (D-MN) · May 20, 2025
- Troy Balderson (R-OH) · Jul 2, 2025
- Beth Van Duyne (R-TX) · Jul 14, 2025
- Robert J. Wittman (R-VA) · Sep 9, 2025
- Jimmy Panetta (D-CA) · Sep 26, 2025
- Suzan K. DelBene (D-WA) · Oct 8, 2025
- Terri A. Sewell (D-AL) · Dec 9, 2025
- Deborah K. Ross (D-NC) · Mar 3, 2026
- Brian K. Fitzpatrick (R-PA) · Jun 22, 2026
Summary
Summary by the Congressional Research Service· describes the “Introduced in House” version
Access to Prescription Digital Therapeutics Act of 2025
This bill provides for Medicare and Medicaid coverage of prescription digital therapeutics (i.e., software applications that are used to prevent, manage, or treat medical conditions). The Centers for Medicare & Medicaid Services must establish a Medicare payment methodology for payments to manufacturers that takes into account certain factors (e.g., ongoing use); manufacturers must report specified information about private payors, subject to civil penalties.
Roll-call votes
No recorded votes on this bill.
Actions
- May 8, 2025 · House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. - May 8, 2025
Introduced in House